US Patent 9790479 Therapeutic nuclease compositions and methods
Patent 9790479 was granted and assigned to University of Washington on October, 2017 by the United States Patent and Trademark Office.
All edits
Edits on 30 Oct, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 4 Sep, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 6 Dec, 2023
Golden AI
Edits made to:
Article (+201 characters)
Article
Patent abstract
Hybrid nuclease molecules and methods for treating an immune-related disease or disorder in a mammal, and a pharmaceutical composition for treating an immune-related disease in a mammal.
Edits on 30 Sep, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Jeffrey A. Ledbetter0
Keith Elkon0
Martha Hayden-Ledbetter0
Xizhang Sun0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 09790479 Therapeutic nuclease compositions and methods US Patent 9790479 Therapeutic nuclease compositions and methods
Infobox
Patent Number
09790479
Patent Number
9790479
Edits on 15 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 09790479 Therapeutic nuclease compositions and methods
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
09790479
Date of patent
October 17, 2017
Patent application number
14516161
Date Filed
October 16, 2014
Patent primary examiner
Find more entities like US Patent 9790479 Therapeutic nuclease compositions and methods
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.